RxDoctor Payments Data

Rianne Clark

Nurse Practitioner · Greenwood Village, CONPI 1841765344

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,160in general payments, 2019–2025

Across 220 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$920
  • Novo Nordisk$454
  • Pfizer$399
  • Amgen$313
  • Viiv Healthcare Company$255
  • Gilead$208
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,160100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,160 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$22,877
Medicare patients
64
Services billed
299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin18$18,263
RybelsusSemaglutide14$17,826
Rosuvastatin Calcium43$731
Omeprazole27$583
Np ThyroidThyroid,pork14$454
Levothyroxine Sodium59$391
Atorvastatin Calcium53$386
Metformin Hcl ErMetformin Hcl19$165
Losartan Potassium22$150
Metformin Hcl12$127
Amlodipine Besylate24$109
Lisinopril16$108
Fluticasone Propionate11$107
Trazodone Hcl18$103
Hydrochlorothiazide12$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$31$18,26318 claims
Novo NordiskRybelsus$454$17,82614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →